2026 NPPES data Hematology & Oncology Physician NPI 1043316656 M.D.
Verify on CMS →

Nanda Biswas, M.D.

Hematology & Oncology Physician in Victorville, California.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
10K
Medicare Part D claims · 488 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
83%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
99/100
▲ 16 pts above national avg 83.1 · Exceptional
Industry payments
$4.8K
189 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Nanda Biswas, M.D. reported a CMS MIPS final score of 99/100 - above the 83.1 national average - and filed 9,502 Medicare Part D claims in 2023.

99/100
MIPS score · +16 vs avg
10K
Part D claims, 2023
83%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Nanda Biswas, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure

99 Top 9% higher than 91% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90+: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Nanda Biswas, M.D. sits

This provider among hematology & oncology physician peers

Across the 4,233 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Nanda Biswas, M.D. writes more Part D claims than 100% of them and scores higher on MIPS quality than 88% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Part D claim volume vs MIPS quality, by specialty percentile

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.148.372.496.6Part D claim volume, percentile in specialtyMIPS quality, percentilePart D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 8Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 40Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 77Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 23Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 60Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 78Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 72Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 25Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 35Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 57Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 47Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 30Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 10Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 73Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 2Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 33Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 47Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 90Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 40Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 0Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 82Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 37Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 38Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 47Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 20Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 70Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 80Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 87Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 67Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 15Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 3Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 75Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 53Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 17Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 45Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 28Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 7Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 88Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 52Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 68Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 53Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 58Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 5Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 43Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 83Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 20Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 18Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 32Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 65Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 62Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 27Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 92Nanda Biswas, M.D.-Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 88
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Nanda Biswas, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Nanda Biswas, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Nanda Biswas, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 09/15/2006

NPI 1043316656

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

9,502 11× vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

99/100 15.9 pts vs avg

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Hematology & Oncology Physician compares to other specialties among California providers

California providers
Behavior Technician - 17.3%Behavior Technician17.3%Marriage & Family Therapist - 5.5%Marriage & Family Therapist5.5%Student in an Organized Health Care Education/Training Program - 5%Student in an Organized Health Care Education/Training Program5%Mental Health Counselor - 3.9%Mental Health Counselor3.9%Pharmacist - 3.5%Pharmacist3.5%Clinical Social Worker - 3.1%Clinical Social Worker3.1%Hematology & Oncology Physician - 0.1%Hematology & Oncology Physician0.1%
Largest specialties in California (% of in-state providers)

Medicare quality performance, MIPS

Nanda Biswas, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
99/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) - 99/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Hematology & Oncology Physician) - 99/100 vs national avg 83.1
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Nanda Biswas, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 12677 HESPERIA RD, Victorville, CA, 92395, with a listed phone of (760) 952-0040. NPI 1043316656 was issued on 09/15/2006.

Medicare Part D records for calendar year 2023 show 9,502 prescription claims written by this provider, covering 488 Medicare beneficiaries and totaling roughly $5.8 million in drug spend, split 16% brand-name and 83% generic by claim count, with an opioid prescribing rate of 4.3%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 99/100 for the 2023 performance year (Quality 82.8), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

12677 HESPERIA RD
Victorville, CA 92395

Provider Details

NPI 1043316656
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 09/15/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

99.0427
Final Score
Avg: 83.1
82.8048
Quality
95
Promoting Interoperability

Reporting: Individual

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Nanda Biswas, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$4.8K

Largest payer

Novartis Pharmaceuticals Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - California MBC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Nanda Biswas, M.D.. To verify Nanda Biswas, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

Nanda Biswas, M.D. - brand share 16.0%
Hematology & Oncology Physician average

16% brand-name claims vs 83% generic, on 9,502 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

9,502
Total Claims
$5.8M
Total Drug Cost
488
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
16,460
Total Day Supply
478,209
Brand vs Generic
16% brand / 83% generic
Brand Drug Cost
$5.5M
Generic Drug Cost
$296K
Opioid Claims
404 (4.3% rate)
Antibiotic Claims
239

Patient Demographics

Average Patient Age
71.4 years
Avg HCC Risk Score
1.87
Gender Split
69% female / 31% male
Age Distribution
<65: 82, 65-74: 224, 75-84: 132, 85+: 50

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Nanda Biswas, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
467
Amlodipine Besylate
393
Levothyroxine Sodium
307
Omeprazole
289
Lisinopril
281
Gabapentin
253
Metformin Hcl
233
Albuterol Sulfate Hfa
Albuterol Sulfate
224
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
221
Losartan Potassium
194

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Nanda Biswas, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

Nanda Biswas, M.D.'s 9,502 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Biswas.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Nanda Biswas, M.D.'s specialty?
Nanda Biswas, M.D. specializes in Hematology & Oncology Physician and practices in Victorville, California. Credentials: M.D..
How much does Nanda Biswas, M.D. prescribe under Medicare Part D?
In 2023, Nanda Biswas, M.D. wrote 9,502 Medicare Part D claims totaling $5.8M in drug costs for 488 beneficiaries.
What is Nanda Biswas, M.D.'s Medicare quality score?
Nanda Biswas, M.D. has a CMS MIPS Final Score of 99/100 (Quality: 82.8). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Nanda Biswas, M.D. located?
Nanda Biswas, M.D. is located at 12677 HESPERIA RD, Victorville, CA, 92395. Phone: (760) 952-0040.
What is Nanda Biswas, M.D.'s NPI number?
Nanda Biswas, M.D.'s National Provider Identifier (NPI) is 1043316656, issued on 09/15/2006.
Does Nanda Biswas, M.D. prescribe more brand-name or generic drugs?
Nanda Biswas, M.D.'s prescribing is 16% brand-name and 83% generic drugs by claim count, with $5.5M in brand drug costs.
Does Nanda Biswas, M.D. prescribe opioids?
Yes, Nanda Biswas, M.D. had 404 opioid claims in 2023 with an opioid prescribing rate of 4.3%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Nanda Biswas, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Nanda Biswas, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Amlodipine Besylate, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Nanda Biswas, M.D. accept Medicare?
Nanda Biswas, M.D. appears in CMS Medicare data with 9,502 Part D claims and 488 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Nanda Biswas, M.D.'s credentials?
Nanda Biswas, M.D.'s NPI is 1043316656 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.